Clinical Trials Directory

Trials / Completed

CompletedNCT01596231

Kudzu Treatment for Alcohol Abuse

Isoflavone (Kudzu) Extract Effects on Alcohol Drinking: Single Dose Pretreatment Study

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Mclean Hospital · Academic / Other
Sex
All
Age
21 Years – 40 Years
Healthy volunteers
Accepted

Summary

This is a study designed to test whether a single administration of kudzu extract (2 mg) will significantly reduce the number of drinks consumed during a single 1 ½ hours drinking session when given as pretreatment 2 ½ hours before the drinking session.

Detailed description

In a laboratory experimental setting, subjects will be treated with placebo or 2 grams of kudzu extract 2.5 hours before an afternoon drinking session. The investigators hypothesis is that the kudzu pretreatment will reduce alcohol consumption in this free choice, self-administration paradigm.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTKudzuKudzu (2 mg) will be administered as a pretreatment 2 ½ hours before a drinking session to see if it will significantly reduce the number of drinks consumed during a single 1 ½ hours drinking session.
DIETARY_SUPPLEMENTPlaceboPlacebo will be administered as a pretreatment 2 ½ hours before a drinking session

Timeline

Start date
2010-05-01
Primary completion
2013-05-01
Completion
2014-07-01
First posted
2012-05-10
Last updated
2014-10-21
Results posted
2014-10-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01596231. Inclusion in this directory is not an endorsement.